Your browser doesn't support javascript.
loading
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study).
Augustin, Matthias; Sommer, Rachel; Daudén, Esteban; Laws, Philip; de Jong, Elke; Fabbrocini, Gabriella; Naldi, Luigi; Navarini, Alexander; Lambert, Jo; Reguiai, Ziad; Gerdes, Sascha; Massana, Eric; Obis, Teresa; Kasujee, Ismail; Mrowietz, Ulrich.
Afiliación
  • Augustin M; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany m.augustin@uke.de.
  • Sommer R; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Daudén E; Instituto de Investigación Sanitaria La Princesa (IIS-IP), La Princesa University Hospital, Madrid, Spain.
  • Laws P; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • de Jong E; Department of Dermatology, Radboud University Medical Center (Radboudumc), Nijmegen, The Netherlands.
  • Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Naldi L; Division of Dermatology, San Bortolo Hospital, Vicenza, Italy.
  • Navarini A; Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Lambert J; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Reguiai Z; Department of Dermatology, Polyclinic Courlancy, Reims, France.
  • Gerdes S; Center for Inflammatory Skin Diseases, Department of Dermatology, Venereology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Massana E; Almirall GMA, Barcelona, Spain.
  • Obis T; Almirall GMA, Barcelona, Spain.
  • Kasujee I; Almirall GMA, Barcelona, Spain.
  • Mrowietz U; Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
BMJ Open ; 13(2): e060536, 2023 02 15.
Article en En | MEDLINE | ID: mdl-36792337
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Calidad de Vida Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies Aspecto: Ethics / Patient_preference Límite: Adult / Humans Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Calidad de Vida Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies Aspecto: Ethics / Patient_preference Límite: Adult / Humans Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido